Since EZH2 drives CSC self-renewal and is associated with poor prognosis in most malignancies, it is conceivable that these cells contribute to the maintenance of the tumoral mass and are implicated in CCA chemoresistance. The gene discussed is EZH2; the disease is cholangiocarcinoma.